PUBLISHER: Value Market Research | PRODUCT CODE: 1402205
PUBLISHER: Value Market Research | PRODUCT CODE: 1402205
Global In Vitro Lung Model Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
The global demand for In Vitro Lung Model Market is presumed to reach the market size of nearly USD 1290.54 MN by 2030 from USD 336.66 MN in 2022 with a CAGR of 18.29% under the study period 2023 - 2030.
An in vitro lung model is an artificial representation or simulation of the human lung created for research, drug development, and testing purposes outside of a living organism. These models replicate certain aspects of lung structure and function to study respiratory physiology, diseases, drug responses, and toxicology.
MARKET DYNAMICS
The in vitro lung model market growth is fueled by the increasing prevalence of respiratory diseases like asthma and COPD, which necessitates reliable research models. In vitro lung models provide a controlled environment to study disease mechanisms, drug responses, and potential treatments, catering to the rising demand for effective solutions. Pharmaceutical industries heavily rely on these models to expedite drug development and testing for respiratory conditions, reducing reliance on animal testing and streamlining the assessment of drug interactions and toxicity. Additionally, as personalized medicine gains traction, in vitro lung models are vital in predicting individual patient responses to treatments, aiding in the development of targeted therapies. Technological advancements, including tissue engineering and 3D printing, enhance the accuracy and sophistication of these models, augmenting their resemblance to actual lung tissue and function. Moreover, regulatory pressures to reduce animal testing and advancements in inhalation toxicology studies further drive the adoption of in vitro lung models.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in vitro lung model. The growth and trends of in vitro lung model industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the in vitro lung model market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- 2D Model
- 3D Model
By Application
- Drug Discovery & Toxicology Studies
- Physiological Research
- 3D Model Development
- Others
By End-Use
- Academic Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the In Vitro Lung Model market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In Vitro Lung Model market include Epithelix, MATTEK, Lonza, Emulate, AlveoliX AG, Nortis, CN Bio Innovations Ltd, MIMETAS, InSphero, ATTC Global. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . IN VITRO LUNG MODEL - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY TYPE
- 5.1 Overview by Type
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Type
- 5.4 2D Model Historic and Forecast Sales by Regions
- 5.5 3D Model Historic and Forecast Sales by Regions
6 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY APPLICATION
- 6.1 Overview by Application
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Application
- 6.4 Drug Discovery & Toxicology Studies Historic and Forecast Sales by Regions
- 6.5 Physiological Research Historic and Forecast Sales by Regions
- 6.6 3D Model Development Historic and Forecast Sales by Regions
- 6.7 Others Historic and Forecast Sales by Regions
7 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY END-USE
- 7.1 Overview by End-use
- 7.2 Historical and Forecast Data
- 7.3 Analysis by End-use
- 7.4 Academic Research Institutes Historic and Forecast Sales by Regions
- 7.5 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
- 7.6 Others Historic and Forecast Sales by Regions
8 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE IN VITRO LUNG MODEL COMPANIES
- 9.1. In Vitro Lung Model Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF IN VITRO LUNG MODEL INDUSTRY
- 10.1. Company Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Epithelix
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. MATTEK
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. Lonza
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. Emulate
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. AlveoliX AG
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. Nortis
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. CN Bio Innovations Ltd
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. MIMETAS
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
- 10.11. InSphero
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
- 10.12. ATTC Global
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Type (USD MN)
- 2D Model Market Sales by Geography (USD MN)
- 3D Model Market Sales by Geography (USD MN)
- Analysis Market by Application (USD MN)
- Drug Discovery & Toxicology Studies Market Sales by Geography (USD MN)
- Physiological Research Market Sales by Geography (USD MN)
- 3D Model Development Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis by End-use (USD MN)
- Academic Research Institutes Market Sales by Geography (USD MN)
- Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global In Vitro Lung Model Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of In Vitro Lung Model Report
- Market Research Process
- Market Research Methodology
- Global In Vitro Lung Model Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Type
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by End-use
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Type (USD MN)
- 2D Model Market Sales by Geography (USD MN)
- 3D Model Market Sales by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Drug Discovery & Toxicology Studies Market Sales by Geography (USD MN)
- Physiological Research Market Sales by Geography (USD MN)
- 3D Model Development Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by End-use (USD MN)
- Academic Research Institutes Market Sales by Geography (USD MN)
- Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
